Biotech · Private company
Alterity Therapeutics
Track this companyFree. Adds Alterity Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ATH434Phase 2 · Multiple System AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- ATH434 dose level 1Phase 2 · Multiple System AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- ATH434 dose level 2Phase 2 · Multiple System AtrophyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Biomarker Study of ATH434 in Participants With MSAPHASE2 · COMPLETED · started May 23, 2023ClinicalTrials.gov NCT05864365 · fetched Nov 12, 2026
- Study of ATH434 in Participants with Multiple System AtrophyPHASE2 · COMPLETED · started Jul 1, 2022ClinicalTrials.gov NCT05109091 · fetched Nov 12, 2026